Coexpression cluster:C520: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:24, 17 September 2013
Full id: C520_Natural_CD14_CD8_Basophils_CD4_Peripheral_CD34
Phase1 CAGE Peaks
Hg19::chr10:11222326..11222339,- | p@chr10:11222326..11222339 - |
Hg19::chr10:11222427..11222442,- | p@chr10:11222427..11222442 - |
Hg19::chr10:17071741..17071777,+ | p@chr10:17071741..17071777 + |
Hg19::chr13:32889208..32889236,+ | p3@BRCA2 |
Hg19::chr13:33002636..33002647,+ | p@chr13:33002636..33002647 + |
Hg19::chr15:65282401..65282422,+ | p@chr15:65282401..65282422 + |
Hg19::chr17:33569466..33569477,+ | p@chr17:33569466..33569477 + |
Hg19::chr17:65437348..65437360,- | p@chr17:65437348..65437360 - |
Hg19::chr19:18597484..18597505,+ | p@chr19:18597484..18597505 + |
Hg19::chr1:160679034..160679048,+ | p@chr1:160679034..160679048 + |
Hg19::chr1:206751790..206751814,+ | p@chr1:206751790..206751814 + |
Hg19::chr1:221952092..221952101,+ | p@chr1:221952092..221952101 + |
Hg19::chr22:36553418..36553428,+ | p@chr22:36553418..36553428 + |
Hg19::chr4:40201863..40201881,- | p@chr4:40201863..40201881 - |
Hg19::chr5:43018291..43018327,+ | p2@ENST00000509036 |
Hg19::chr6:37016760..37016773,+ | p@chr6:37016760..37016773 + |
Hg19::chr6:37139954..37139971,- | p@chr6:37139954..37139971 - |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0033593 | BRCA2-MAGE-D1 complex | 0.00150123631225715 |
GO:0033595 | response to genistein | 0.00150123631225715 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 0.00150123631225715 |
GO:0033598 | mammary gland epithelial cell proliferation | 0.00150123631225715 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 0.00150123631225715 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 0.00150123631225715 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 0.00150123631225715 |
GO:0048478 | replication fork protection | 0.00150123631225715 |
GO:0007141 | male meiosis I | 0.00150123631225715 |
GO:0001556 | oocyte maturation | 0.00150123631225715 |
GO:0010225 | response to UV-C | 0.00150123631225715 |
GO:0010332 | response to gamma radiation | 0.00150123631225715 |
GO:0033205 | cytokinesis during cell cycle | 0.0017156986425796 |
GO:0001833 | inner cell mass cell proliferation | 0.0017156986425796 |
GO:0031573 | intra-S DNA damage checkpoint | 0.00187654539032144 |
GO:0045931 | positive regulation of progression through mitotic cell cycle | 0.00187654539032144 |
GO:0001832 | blastocyst growth | 0.00191066439741819 |
GO:0048599 | oocyte development | 0.00191066439741819 |
GO:0009994 | oocyte differentiation | 0.00191066439741819 |
GO:0010165 | response to X-ray | 0.00191066439741819 |
GO:0007140 | male meiosis | 0.00191066439741819 |
GO:0051298 | centrosome duplication | 0.00191066439741819 |
GO:0043015 | gamma-tubulin binding | 0.00200164841634287 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 0.00200164841634287 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 0.0024726245143059 |
GO:0014070 | response to organic cyclic substance | 0.0024726245143059 |
GO:0000724 | double-strand break repair via homologous recombination | 0.0024726245143059 |
GO:0050680 | negative regulation of epithelial cell proliferation | 0.0024726245143059 |
GO:0000725 | recombinational repair | 0.0024726245143059 |
GO:0007569 | cell aging | 0.0024726245143059 |
GO:0010212 | response to ionizing radiation | 0.0024726245143059 |
GO:0030879 | mammary gland development | 0.0024726245143059 |
GO:0007098 | centrosome cycle | 0.0024726245143059 |
GO:0001824 | blastocyst development | 0.0024726245143059 |
GO:0033261 | regulation of progression through S phase | 0.00257354796386941 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 0.00259304453935326 |
GO:0008156 | negative regulation of DNA replication | 0.00259304453935326 |
GO:0048477 | oogenesis | 0.00259304453935326 |
GO:0000084 | S phase of mitotic cell cycle | 0.00259304453935326 |
GO:0051297 | centrosome organization and biogenesis | 0.00259304453935326 |
GO:0031023 | microtubule organizing center organization and biogenesis | 0.00259304453935326 |
GO:0051053 | negative regulation of DNA metabolic process | 0.00259304453935326 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 0.00259304453935326 |
GO:0007281 | germ cell development | 0.00259304453935326 |
GO:0051320 | S phase | 0.00280230778288002 |
GO:0043627 | response to estrogen stimulus | 0.00287193033649194 |
GO:0035264 | multicellular organism growth | 0.0030024726245143 |
GO:0045787 | positive regulation of progression through cell cycle | 0.0030024726245143 |
GO:0000077 | DNA damage checkpoint | 0.00306374757603501 |
GO:0007568 | aging | 0.00312257152949488 |
GO:0008585 | female gonad development | 0.00316624385857872 |
GO:0031570 | DNA integrity checkpoint | 0.00316624385857872 |
GO:0006275 | regulation of DNA replication | 0.00316624385857872 |
GO:0046545 | development of primary female sexual characteristics | 0.00316624385857872 |
GO:0046660 | female sex differentiation | 0.00316624385857872 |
GO:0050678 | regulation of epithelial cell proliferation | 0.00321693495483676 |
GO:0007346 | regulation of progression through mitotic cell cycle | 0.00335869819013464 |
GO:0009411 | response to UV | 0.00335869819013464 |
GO:0050673 | epithelial cell proliferation | 0.00335869819013464 |
GO:0000910 | cytokinesis | 0.00336640870021301 |
GO:0007292 | female gamete generation | 0.00336640870021301 |
GO:0006302 | double-strand break repair | 0.00336640870021301 |
GO:0008629 | induction of apoptosis by intracellular signals | 0.00336640870021301 |
GO:0048589 | developmental growth | 0.00336640870021301 |
GO:0030141 | secretory granule | 0.00336640870021301 |
GO:0048545 | response to steroid hormone stimulus | 0.00336640870021301 |
GO:0007584 | response to nutrient | 0.00374221225664102 |
GO:0006289 | nucleotide-excision repair | 0.00374221225664102 |
GO:0042770 | DNA damage response, signal transduction | 0.00374221225664102 |
GO:0048469 | cell maturation | 0.00386032194580411 |
GO:0048732 | gland development | 0.00389052790782135 |
GO:0051052 | regulation of DNA metabolic process | 0.00408669885003336 |
GO:0001701 | in utero embryonic development | 0.0041129761979648 |
GO:0008406 | gonad development | 0.00416342870599317 |
GO:0048608 | reproductive structure development | 0.00416342870599317 |
GO:0021700 | developmental maturation | 0.00418765918682259 |
GO:0000075 | cell cycle checkpoint | 0.00436723290838445 |
GO:0031667 | response to nutrient levels | 0.00456071791065464 |
GO:0045137 | development of primary sexual characteristics | 0.00456071791065464 |
GO:0003697 | single-stranded DNA binding | 0.00457877075238432 |
GO:0010033 | response to organic substance | 0.00459637784493548 |
GO:0009991 | response to extracellular stimulus | 0.00483324861507181 |
GO:0015631 | tubulin binding | 0.00484736544198695 |
GO:0051327 | M phase of meiotic cell cycle | 0.00487460261391734 |
GO:0007126 | meiosis | 0.00487460261391734 |
GO:0051321 | meiotic cell cycle | 0.00495757107768641 |
GO:0009725 | response to hormone stimulus | 0.005245699298002 |
GO:0009416 | response to light stimulus | 0.00546517488956537 |
GO:0007548 | sex differentiation | 0.00546517488956537 |
GO:0051329 | interphase of mitotic cell cycle | 0.00567133717963813 |
GO:0003006 | reproductive developmental process | 0.00574099161170867 |
GO:0051325 | interphase | 0.00587440296100625 |
GO:0009792 | embryonic development ending in birth or egg hatching | 0.00606882764529487 |
GO:0043009 | chordate embryonic development | 0.00606882764529487 |
GO:0009314 | response to radiation | 0.00638420494896726 |
GO:0005813 | centrosome | 0.00806914517838219 |
GO:0007420 | brain development | 0.00860502463520594 |
GO:0005815 | microtubule organizing center | 0.00900741787354291 |
GO:0043566 | structure-specific DNA binding | 0.00964430600601564 |
GO:0006261 | DNA-dependent DNA replication | 0.00981005907019525 |
GO:0009628 | response to abiotic stimulus | 0.00981005907019525 |
GO:0006310 | DNA recombination | 0.0115977864123396 |
GO:0007283 | spermatogenesis | 0.0120665409249349 |
GO:0006917 | induction of apoptosis | 0.0120665409249349 |
GO:0048232 | male gamete generation | 0.0120665409249349 |
GO:0012502 | induction of programmed cell death | 0.0120665409249349 |
GO:0008285 | negative regulation of cell proliferation | 0.0126272213180508 |
GO:0007417 | central nervous system development | 0.0129464415919424 |
GO:0009790 | embryonic development | 0.0129464415919424 |
GO:0051301 | cell division | 0.0133746507819274 |
GO:0043065 | positive regulation of apoptosis | 0.013832820305798 |
GO:0043068 | positive regulation of programmed cell death | 0.013832820305798 |
GO:0007276 | gamete generation | 0.0140292526171996 |
GO:0022414 | reproductive process | 0.015978376053937 |
GO:0000279 | M phase | 0.015978376053937 |
GO:0016563 | transcription activator activity | 0.0159959317409469 |
GO:0019953 | sexual reproduction | 0.0161671602858463 |
GO:0045934 | negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0162337079189841 |
GO:0000278 | mitotic cell cycle | 0.0164505222788515 |
GO:0016023 | cytoplasmic membrane-bound vesicle | 0.0173313460439444 |
GO:0031988 | membrane-bound vesicle | 0.0173313460439444 |
GO:0000074 | regulation of progression through cell cycle | 0.0173313460439444 |
GO:0006260 | DNA replication | 0.0173313460439444 |
GO:0051726 | regulation of cell cycle | 0.0173852850354941 |
GO:0022403 | cell cycle phase | 0.0177265983751325 |
GO:0031324 | negative regulation of cellular metabolic process | 0.0181578106339675 |
GO:0006281 | DNA repair | 0.0185349491151119 |
GO:0031410 | cytoplasmic vesicle | 0.0199382947721653 |
GO:0031982 | vesicle | 0.0201095840897702 |
GO:0009892 | negative regulation of metabolic process | 0.0201396625275113 |
GO:0006974 | response to DNA damage stimulus | 0.0205359959661436 |
GO:0042127 | regulation of cell proliferation | 0.0213357524378365 |
GO:0015630 | microtubule cytoskeleton | 0.0233425315319383 |
GO:0009719 | response to endogenous stimulus | 0.0237060898263891 |
GO:0042981 | regulation of apoptosis | 0.0253542132736764 |
GO:0043067 | regulation of programmed cell death | 0.0254327092900035 |
GO:0042221 | response to chemical stimulus | 0.0258168813991084 |
GO:0008092 | cytoskeletal protein binding | 0.0262389998924946 |
GO:0022402 | cell cycle process | 0.0270006530981502 |
GO:0009605 | response to external stimulus | 0.0271509310188222 |
GO:0007399 | nervous system development | 0.0304931971510956 |
GO:0008283 | cell proliferation | 0.0315048183839881 |
GO:0007049 | cell cycle | 0.0352318116359091 |
GO:0006915 | apoptosis | 0.0356543624161074 |
GO:0012501 | programmed cell death | 0.0356983641700873 |
GO:0008219 | cell death | 0.0370917706538638 |
GO:0016265 | death | 0.0370917706538638 |
GO:0044430 | cytoskeletal part | 0.0372468901257315 |
GO:0048522 | positive regulation of cellular process | 0.0384477702521698 |
GO:0048518 | positive regulation of biological process | 0.0425150123631226 |
GO:0048523 | negative regulation of cellular process | 0.0450765955864582 |
GO:0048513 | organ development | 0.0450765955864582 |
GO:0048519 | negative regulation of biological process | 0.0463911456493583 |
GO:0006950 | response to stress | 0.0476496304825517 |
GO:0048468 | cell development | 0.0480780552310047 |
GO:0006259 | DNA metabolic process | 0.0480780552310047 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
bone marrow | 2.65e-55 | 76 |
hematopoietic system | 1.75e-53 | 98 |
blood island | 1.75e-53 | 98 |
bone element | 2.24e-50 | 82 |
immune system | 1.47e-49 | 93 |
hemolymphoid system | 2.76e-47 | 108 |
skeletal element | 8.02e-45 | 90 |
skeletal system | 4.00e-39 | 100 |
lateral plate mesoderm | 6.69e-19 | 203 |
musculoskeletal system | 1.32e-18 | 167 |
connective tissue | 4.51e-18 | 371 |
mesoderm | 8.95e-08 | 315 |
mesoderm-derived structure | 8.95e-08 | 315 |
presumptive mesoderm | 8.95e-08 | 315 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.00176401 |
MA0004.1 | 0.631966 |
MA0006.1 | 0.731819 |
MA0007.1 | 0.599001 |
MA0009.1 | 0.621697 |
MA0014.1 | 0.249137 |
MA0017.1 | 0.425352 |
MA0019.1 | 0.901513 |
MA0024.1 | 0.525161 |
MA0025.1 | 0.747404 |
MA0027.1 | 2.20546 |
MA0028.1 | 0.776012 |
MA0029.1 | 0.542771 |
MA0030.1 | 0.532314 |
MA0031.1 | 0.474026 |
MA0038.1 | 0.817744 |
MA0040.1 | 0.548121 |
MA0041.1 | 0.236024 |
MA0042.1 | 0.211928 |
MA0043.1 | 0.621991 |
MA0046.1 | 0.611559 |
MA0048.1 | 0.0663643 |
MA0050.1 | 1.14756 |
MA0051.1 | 1.47078 |
MA0052.1 | 0.551663 |
MA0055.1 | 0.0085634 |
MA0056.1 | 0 |
MA0057.1 | 0.164004 |
MA0058.1 | 1.46022 |
MA0059.1 | 0.907445 |
MA0060.1 | 0.0509127 |
MA0061.1 | 0.640118 |
MA0063.1 | 0 |
MA0066.1 | 0.302992 |
MA0067.1 | 0.924196 |
MA0068.1 | 0.111262 |
MA0069.1 | 0.607975 |
MA0070.1 | 0.597583 |
MA0071.1 | 1.36955 |
MA0072.1 | 0.593415 |
MA0073.1 | 0.102168 |
MA0074.1 | 0.808577 |
MA0076.1 | 0.493997 |
MA0077.1 | 0.586275 |
MA0078.1 | 0.995054 |
MA0081.1 | 0.907903 |
MA0083.1 | 0.628701 |
MA0084.1 | 1.10674 |
MA0087.1 | 0.591148 |
MA0088.1 | 0.320704 |
MA0089.1 | 0 |
MA0090.1 | 0.174619 |
MA0091.1 | 0.223914 |
MA0092.1 | 1.08245 |
MA0093.1 | 1.21412 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 1.52405 |
MA0101.1 | 0.372085 |
MA0103.1 | 0.34743 |
MA0105.1 | 0.492971 |
MA0106.1 | 0.33677 |
MA0107.1 | 0.259598 |
MA0108.2 | 0.471286 |
MA0109.1 | 0 |
MA0111.1 | 0.541878 |
MA0113.1 | 0.350573 |
MA0114.1 | 0.072201 |
MA0115.1 | 0.850405 |
MA0116.1 | 0.264652 |
MA0117.1 | 1.58019 |
MA0119.1 | 1.39041 |
MA0122.1 | 0.681203 |
MA0124.1 | 0.810546 |
MA0125.1 | 0.730403 |
MA0130.1 | 0 |
MA0131.1 | 1.02939 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.650071 |
MA0136.1 | 0.30842 |
MA0139.1 | 0.140313 |
MA0140.1 | 0.74193 |
MA0141.1 | 0.151722 |
MA0142.1 | 0.445733 |
MA0143.1 | 0.350722 |
MA0144.1 | 1.2999 |
MA0145.1 | 0.838342 |
MA0146.1 | 0.0313344 |
MA0147.1 | 0.569428 |
MA0148.1 | 0.240905 |
MA0149.1 | 0.261654 |
MA0062.2 | 0.148712 |
MA0035.2 | 0.268747 |
MA0039.2 | 0.243085 |
MA0138.2 | 0.38342 |
MA0002.2 | 0.393994 |
MA0137.2 | 1.29199 |
MA0104.2 | 0.420925 |
MA0047.2 | 0.326636 |
MA0112.2 | 0.00512484 |
MA0065.2 | 0.098884 |
MA0150.1 | 0.170499 |
MA0151.1 | 0 |
MA0152.1 | 0.274535 |
MA0153.1 | 0.714423 |
MA0154.1 | 0.280624 |
MA0155.1 | 0.0782503 |
MA0156.1 | 0.4018 |
MA0157.1 | 0.421609 |
MA0158.1 | 0 |
MA0159.1 | 0.0787617 |
MA0160.1 | 0.252705 |
MA0161.1 | 0 |
MA0162.1 | 0.0369674 |
MA0163.1 | 0.0193966 |
MA0164.1 | 0.948242 |
MA0080.2 | 1.21447 |
MA0018.2 | 0.337929 |
MA0099.2 | 0.754549 |
MA0079.2 | 0.0198059 |
MA0102.2 | 1.14323 |
MA0258.1 | 0.0605489 |
MA0259.1 | 0.28219 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
EBF1#1879 | 6 | 3.14345888702435 | 0.0082556798385042 | 0.0325327301306848 |
FOS#2353 | 6 | 3.17574893255097 | 0.00785510561119647 | 0.0322577608889489 |
FOSL2#2355 | 6 | 5.97536491925707 | 0.000297459514596548 | 0.00310446429948525 |
MEF2A#4205 | 4 | 4.41017197873978 | 0.0110070197206115 | 0.040493223875478 |
NFKB1#4790 | 8 | 2.58261808197357 | 0.00612962073262582 | 0.0271029407152713 |
POLR2A#5430 | 15 | 1.89481162637477 | 0.00045412137082633 | 0.00422032228579205 |
SPI1#6688 | 6 | 2.89564359124332 | 0.0122532128785811 | 0.0444190662903897 |
STAT1#6772 | 5 | 6.09017279329388 | 0.000995541757041492 | 0.00714348234721102 |
WRNIP1#56897 | 2 | 12.919995805809 | 0.0102923120972492 | 0.0382329284412098 |
YY1#7528 | 8 | 2.31113917640181 | 0.0121921825045688 | 0.0442054972607069 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.